【持续性肾脏替代治疗CRRT英文ppt课件】The clinical application of CRRT—current status (76p).pptVIP

R3郭韋宏/F1李岳庭/VS陳德全 July 29,2009;Critically ill patient;Acute kidney injury: RIFLE criteria;Acute kidney injury: RIFLE criteria;IHD CRRT;;What is an optimal application for CRRT ?;CVVH CVVHDF;What is an optimal application for CRRT ?;Relationship between effluent flow rate and solute clearance;What is the optimal dose？;High dose standard dose;Acute Renal Failure Trial Network (ATN) study;NEJM 2008, 359,7-20;Acute Renal Failure Trial Network (ATN) study;The Randomized Evaluation of Normal versus Augmented Level of RRT (RENAL) study;What is the optimal dose？;What is an optimal application for CRRT ?;Early Late initiation;Early Late initiation;;What is an optimal application for CRRT ?;Complications of CRRT (1);Complications of CRRT (2);;How to select RRT?;CRRT in renal application ;CRRT in non-renal application;How to prescribe ultrafiltration;Protocol for Early Goal-Directed Therapy of severe sepsis and septic shock;Early goal-directed therapy;Acute neurologic injury;Sepsis and multiple organ failure;;Acute decompensated heart failure;Cardiorenal syndrome;Classification of Cardiorenal Syndrome Proposed By Ronco and Colleagues;Liver disease;臨床演練; 67 y/o man (BW: 79kg) , hx of ESRD in uremic stage, s/p AV shunt creation on 6/18 HCC s/p TAE Liver cirrhosis ;; CVVHD order (Prismaflex) ; CVVHDF order (Prismaflex) ;?;Thanks for your attention！！;; CVVH 的併發症;;;;;;Cascade of SIRS / Sepsis;* ;;;* ;CRRT 特點; CVVH的技術;A filtration rate of more than 25 - 30% greatly increases blood viscosity within the circuit, risking clot and malfunction.;Sludging problems are reduced, but the efficiency of ultrafiltration is compromised, as the ultrafiltrate now contains a portion of the replacement fluid. ;;*;*;;;;;;;;;;Discussion (1);Discussion (2): Limitation of the study;Discussion (3)